Rifaximin versus Ciprofloxacin for the Treatment of Traveler's Diarrhea: A Randomized, Double‐Blind Clinical Trial
Open Access
- 1 December 2001
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (11) , 1807-1815
- https://doi.org/10.1086/323814
Abstract
Rifaximin is a poorly absorbed rifamycin derivative under investigation for treatment of infectious diarrhea. Adult students from the United States iKeywords
This publication has 25 references indexed in Scilit:
- Epidemiology, Etiology, and Impact of Traveler's Diarrhea in JamaicaJAMA, 1999
- Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy. A double-blind, randomised trialCurrent Medical Research and Opinion, 1997
- RifaximinDrugs, 1995
- Prevention and Treatment of Traveler's DiarrheaNew England Journal of Medicine, 1993
- Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivativeDiagnostic Microbiology and Infectious Disease, 1993
- Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to MexicoPublished by American Medical Association (AMA) ,1992
- Treatment of Small Intestine Bacterial Overgrowth with Rifaximin, a Non-Absorbable RifamycinJournal of International Medical Research, 1988
- Ciprofloxacin or Trimethoprim-Sulfamethoxazole as Initial Therapy for Travelers' DiarrheaAnnals of Internal Medicine, 1987
- Bicozamycin, A Poorly Absorbable Antibiotic, Effectively Treats Travelers' DiarrheaAnnals of Internal Medicine, 1983
- Travelers' Diarrhea and ToxigenicEscherichia coliNew England Journal of Medicine, 1975